Guangzhou Modern Hospital is a national j medical unit dedicated to providing modern medical services for Chinese courts, overseas Chinese and national j patients.
Guangzhou Modern Hospital, founded in 2005, is a secondary comprehensive hospital in China, which is characterized by tumor minimally invasive and integrates medical treatment, rehabilitation, prevention and health care. It is a national jJCI certified hospital, a designated hospital for Guangzhou medical insurance, a provincial medical insurance network hospital, a designated hospital for provincial industrial injury insurance, and a designated hospital for provincial enterprise public medical care.
In 2015, Singapore Pengruili Land Group officially invested in the hospital, making Guangzhou Modern Hospital a joint venture JCI hospital in Singapore. On July 3, 2016, Guangzhou Modern Hospital was officially renamed as Sundance Modern Hospital.
The hospital has a building area of 20000 square meters and nearly 500 employees. It has an expert team composed of well-known scholars, professors and returned doctors at home and abroad, and many experts serve as professional associations at provincial and municipal levels or above.
The hospital focuses on tumor, and has internal medicine, surgery (general surgery, anorectal surgery, orthopaedic surgery, etc.), gynecology, reproductive health infertility, pediatrics, traditional Chinese medicine, traditional Chinese medicine physiotherapy, eye/ear nose throat, stomatology, physical examination, and blood purification center. ICU, Medical Imaging Center, Clinical Imaging Center, Clinical Examination Center and other corresponding auxiliary departments.
The hospital has successively won the honorary titles and qualifications designated by the Ministry of Health of China, such as "Member Unit of China Anti Cancer Association", "Postgraduate Internship Base of Health Law of Southern Medical University", "National jJCI Certified Hospital", "Teaching Base of Guangdong Pharmaceutical University", and "Clinical Application Base of Nano Knife". It has always been established with a number of national j hospitals in Indonesia, the Philippines, Vietnam, South Africa Europe, Vietnam, South Africa, Europe and China.
The hospital has always adhered to the concept of "prospering the hospital through science and technology, strengthening the hospital through talents", and attached importance to and encouraged scientific research and innovation. Over the years, clinical staff of the hospital have actively participated in scientific research projects. Peng Xiaochi, director of key oncology specialty, published the professional paper "Important ways of hepatitis B virus related hepatocellular carcinoma based on crosstalk and network verification", the core journal of SCI, "Genetic and Molecular Research" magazine; The Feasibility Study Report of Argon Helium Knife in the Treatment of Postoperative Recurrence and Metastasis of Three Negative Breast Cancer declared by Director Dai Wenyan, and the Risk Reduction Analysis of Nano Knife and Gemcitabine, Radiotherapy, Gemcitabine Treatment for Locally Advanced Pancreatic Cancer declared by Director Huang Deliang, were successfully approved in the application of Guangzhou Medical and Health Technology Project. The hospital has published dozens of academic papers in Chinese, provincial and municipal professional journals.
The hospital practices the medical concept of "humanistic care" and introduces a good overseas management model. According to the internationally recognized standard of medical service quality in Singapore, the hospital provides more than 60 value-added services such as decorating family wards, multilingual translation, shuttle services, medical guidance services, traditional festival celebrations, religious services, and accompanied shopping tours, Let patients feel the humanistic care of the hospital in the process of treatment.
